Price to Sales ratio Analysis of Spero Therapeutics Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Good PS
0.988
Period Ending - Dec-22
Very Good PS
0.997
Growth
-0.991 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
171.29
PS Analysis of Spero Therapeutics Inc
P/S Ratio of Spero Therapeutics Inc with value of 171.29 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of SPRO has fallen by -0.991 % Compared to previous Financial Year. |
PS Ratio with value of 3.41 was highest in Year Dec-20 in last Five Years. |
PS Ratio of SPRO trending down for at least three Years. |
Latest PS Ratio with value of 0.988 is lower than Average PS of 1.84 in last five years. |
Other PS Related Info of SPRO that may interest you.
Spero Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
SPRO | 1.42 | 1.42 | 0 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Very Low Value Stock |
FY - Historical Price to Sales of Spero Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 0.988 | 0.997 | 2.40 | 3.41 | 1.42 | 5.73 | 1.86 |
Change | -0.991 % | -58.50 % | -29.47 % | 139.76 % | -75.20 % | 208.67 % | -82.12 % |
FY Chart of Price to Sales of Spero Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)